Belize vs Libya: Access to anti-retroviral drugs, male
Belize
48.0%
in 2024
Libya
49.0%
in 2023
Belize rank
120th
Libya rank
119th
Access to anti-retroviral drugs, male over time
- Belize
- Libya
How they compare
Libya currently reports 49.0% against 48.0% in Belize, a difference of 1.0%.
Across all 24 years both countries report, Libya has been ahead every year.
Belize ranks 120th and Libya ranks 119th of 141 countries.
Libya has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Belize | Libya | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 8.9% | 29.0% | 20.1% | Libya |
| 2010s | 30.8% | 63.9% | 33.1% | Libya |
| 2020s | 40.8% | 47.8% | 7.0% | Libya |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Belize or Libya?
- Libya, at 49.0% against 48.0% in Belize as of 2023.
- What is the difference in access to anti-retroviral drugs, male between Belize and Libya?
- 1.0%, with Libya ahead.
- How many years of comparable data are there for Belize and Libya?
- 24 years are reported by both, from 2000 to 2023.
- How do Belize and Libya rank globally for access to anti-retroviral drugs, male?
- Belize ranks 120th and Libya ranks 119th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.